https://www.sjordanassociates.com/blog/bid/407645/The-Year-We-Decided-to-Live-Forever2015-12-11https://www.sjordanassociates.com/blog/bid/275966/Vital-Signs-48-H-X-Crowdfunding-Healthcare-Companies2015-12-03https://www.sjordanassociates.com/blog/bid/390302/A-Leap-of-Faith-Regenerative-Medicine2015-12-03https://www.sjordanassociates.com/blog/bid/404983/Funding-Circle-In-Talks-With-Singaporean-Fund-Temasek2015-12-03https://www.sjordanassociates.com/blog/bid/404960/The-Best-of-LendIt-USA-20152015-12-03https://www.sjordanassociates.com/blog/bid/163260/1-Oncology-March-14-2011https://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/fierce.pngfiercefierce2015-12-03https://www.sjordanassociates.com/blog/bid/407491/Mutual-Funds-Flail-at-Valuing-Hot-Startups-Like-Uber2015-12-03https://www.sjordanassociates.com/business-developmenthttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/SJA/S_Jordan_Associates_July2022/images/hlb.pnghlbhlbhttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/SJA/S_Jordan_Associates_July2022/images/absolutvision-WYd_PkCa1BY-unsplash.jpgabsolutvisionWYdPkCa1BYunsplashabsolutvisionWYdPkCa1BYunsplash2025-07-09https://www.sjordanassociates.com/blog/bid/407340/Chinese-investors-put-400-million-into-U-S-startups2015-12-03https://www.sjordanassociates.com/blog/bid/230725/Vital-Signs-39-Sharevault-Webinar-Crowdfunding2015-12-03https://www.sjordanassociates.com/blog/bid/275985/Vital-Signs-49-H-X-Crowdfunding-Foundations2015-12-03https://www.sjordanassociates.com/blog/bid/404520/Vital-Signs-136-IPO-lite-SEC-rule-change-means-for-life-sciences-startups2015-12-03https://www.sjordanassociates.com/blog/bid/199885/Vital-Signs-36-Launch-of-CrowdFinance-Portal-H-X-Exchange2015-12-03https://www.sjordanassociates.com/blog/bid/163257/4-Oncology-April-3-20112015-12-03https://www.sjordanassociates.com/blog/bid/304349/Vital-Signs-60-Crowdfunding-in-the-Healthcare-Sector2015-12-03https://www.sjordanassociates.com/blog/bid/407552/First-genetically-modified-humans-could-exist-within-two-yearshttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/xconomy.pngxconomyxconomyhttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/fortune-3.pngfortune3fortune32015-12-03https://www.sjordanassociates.com/blog/bid/380845/Vital-Signs-85-Healthcare-Secrets-From-Insiders-Crowdfunding2015-12-03https://www.sjordanassociates.com/blog/bid/406339/The-Tax-Inversion-Wave-Keeps-Rolling2015-12-03https://www.sjordanassociates.com/blog/bid/399905/Vital-Signs-112-New-Landing-Page-HealthiosXchange2015-12-03https://www.sjordanassociates.com/blog/bid/243067/Vital-Signs-41-Southeast-Venture-Philanthropy-Summit-Crowdfunding2015-12-03https://www.sjordanassociates.com/blog/bid/163253/8-July-6-20112015-12-03https://www.sjordanassociates.com/blog/startup-investors-hit-the-brakes2016-04-15https://www.sjordanassociates.com/blog/innovators-vs-exploiters-drug-pricing-and-the-future-of-pharmahttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/nyt.pngnytnythttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/fortune.pngfortunefortunehttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/lifesci.pnglifescilifesci2016-09-22https://www.sjordanassociates.com/blog/what-no-one-is-telling-you-about-bms-opdivo-immunotherapy-trial-failurehttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/BBC-1.pngBBC1BBC1https://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/medcity.pngmedcitymedcity2016-08-25https://www.sjordanassociates.com/blog/bid/187852/Vital-Signs-30-Crowdfunding-Webinar-February-26th-20132015-12-03https://www.sjordanassociates.com/blog/bid/311052/Vital-Signs-62-Darshana-Varia-Nadkarni-s-Blog-Crowdfunding2015-12-03https://www.sjordanassociates.com/blog/bid/406404/How-Quickly-Are-You-Growing-Old2015-12-03https://www.sjordanassociates.com/blog/bid/382647/Vital-Signs-87-HealthiosXchange-to-speak-at-Growth-Capital-Expo-20142015-12-03https://www.sjordanassociates.com/blog/bid/163233/19-Equity-based-Crowdfunding-Likely-To-Become-Law-Implications-for-Early-Stage-Biotechnology-Companies2015-12-03https://www.sjordanassociates.com/blog/this-is-the-most-important-business-trend-in-pharmahttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/Fortune-5.pngFortune5Fortune52016-06-25https://www.sjordanassociates.com/blog/bid/404383/Vital-Signs-133-2015-PENSCO-Crowdfunding-Report2015-12-03https://www.sjordanassociates.com/blog/bid/404925/Digital-lending-is-heating-up2015-12-03https://www.sjordanassociates.com/blog/bid/404731/Prosper-Raises-165MM-in-Latest-Funding-Round2015-12-03https://www.sjordanassociates.com/blog/first-there-were-wearables.-now-there-are-swallowableshttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/cnbc1.pngcnbc1cnbc12016-05-04https://www.sjordanassociates.com/blog/bid/407488/As-SEC-Votes-On-Title-III-Crowdfunding-Regulations-Investment-Platforms-Are-Divided-On-Impact2015-12-03https://www.sjordanassociates.com/blog/bid/271935/Vital-Signs-47-How-Venture-Capital-and-Crowdfunding-Can-Coexist2015-12-03https://www.sjordanassociates.com/blog/bid/405302/Ron-Suber-Where-We-Are-Today-The-Future-of-Marketplace-Lending-Video2015-12-03https://www.sjordanassociates.com/blog/bid/258920/Vital-Signs-45-PaaS-Crowdfunding-Platform-for-Broker-Dealers2015-12-03https://www.sjordanassociates.com/blog/bid/402894/Vital-Signs-122-Private-Equity-Outperforms-Stock-Market2015-12-03https://www.sjordanassociates.com/blog/bid/401364/Vital-Signs-115-Social-Media-Is-Revolutionizing-Investing2015-12-03https://www.sjordanassociates.com/blog/bid/406883/Intel-shares-more-details-about-its-cancer-cloudhttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/Fortune-5.pngFortune5Fortune52015-12-03https://www.sjordanassociates.com/blog/bid/407166/Sergey-Brin-s-Search-for-a-Parkinson-s-Cure2015-12-03https://www.sjordanassociates.com/blog/bid/407328/No-Scientists-Have-Not-Found-the-Gay-Gene2015-12-03https://www.sjordanassociates.com/blog/bid/401382/Vital-Signs-116-Richard-Swart-Predictions2015-12-03https://www.sjordanassociates.com/blog/bid/293394/Vital-Signs-57-H-X-ASCO-Conference2015-12-03https://www.sjordanassociates.com/blog/bid/406898/Valeant-had-the-hots-for-female-Viagra-Sprout-CEO-sayshttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/xconomy.pngxconomyxconomyhttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/xconomy-1.pngxconomy1xconomy12015-12-03https://www.sjordanassociates.com/blog/bid/407465/Final-Rules-for-Title-III-Retail-Crowdfunding-to-be-Announced-by-SEC-this-Friday2015-12-03https://www.sjordanassociates.com/blog/bid/405297/MIT-Professor-Syndicates-Are-Best-Approach-for-Equity-Crowdfunding-Investors2015-12-03https://www.sjordanassociates.com/blog/bid/406312/Why-Gene-Editing-Technology-Has-Scientists-Excited2015-12-03https://www.sjordanassociates.com/blog/with-crispr-in-humans-on-the-horizon-will-the-public-back-intelliahttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/fortune-3.pngfortune3fortune3https://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/xconomy.pngxconomyxconomy2016-05-05https://www.sjordanassociates.com/blog/bid/324360/Vital-Signs-69-Crowdfund-Insider-Profiles-HealthiosXchange-Crowdfunding2015-12-03https://www.sjordanassociates.com/blog/bid/407405/Drug-Firms-Buy-Pricey-Vouchers-to-Speed-Products-to-Markethttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/xpress.pngxpressxpress2015-12-03https://www.sjordanassociates.com/blog/bid/379755/Vital-Signs-84-Harvard-Business-School-Crowdfundinghttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/wall_street-1.pngwallstreet1wallstreet12015-12-03https://www.sjordanassociates.com/blog/bacteria-or-virus-new-tests-may-identify-whats-causing-your-infectionhttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/wsj-4.pngwsj4wsj42016-03-01https://www.sjordanassociates.com/blog/bid/406533/Closed-End-Fund-CEF-activity-is-reaching-fever2015-12-03https://www.sjordanassociates.com/blog/bid/407505/Why-This-34-Billion-Company-Is-Dipping-a-Toe-Into-Crowdfunding2015-12-03https://www.sjordanassociates.com/blog/bid/404422/Vital-Signs-134-The-Reg-A-Bombshell2015-12-03https://www.sjordanassociates.com/blog/bid/163251/9-Chicago-Wine-Tasting-Alternative-Investment-Symposium2015-12-03https://www.sjordanassociates.com/blog/bid/407185/Boston-based-company-to-sell-next-generation-wristband-to-athleteshttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/san_francisco.pngsanfranciscosanfranciscohttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/wall_street-1.pngwallstreet1wallstreet12015-12-03https://www.sjordanassociates.com/blog/bid/163230/22-H-X-ASCO-20122015-12-03https://www.sjordanassociates.com/blog/bid/191484/Vital-Signs-31-Venture-Philanthropy-L3C-Compassionate-Use-Crowdfunding-White-Paper2015-12-03https://www.sjordanassociates.com/blog/bid/285990/Vital-Signs-55-WSGR-Medical-Device-Conference-Crowdfunding2015-12-03https://www.sjordanassociates.com/blog/bid/163256/5-Oncology-April-17th-20112015-12-03https://www.sjordanassociates.com/blog/bid/406535/Citigroup-Selling-377-Million-of-Bonds-Backed-by-Prosper-Loans2015-12-03https://www.sjordanassociates.com/blog/bid/163232/20-H-X-ASCO-2012-Partnering-Forum2015-12-03https://www.sjordanassociates.com/blog/facebook-napster-billionaire-parker-to-fund-first-ever-crispr-trialhttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/fierce.pngfiercefierce2016-06-24https://www.sjordanassociates.com/blog/bid/406759/Startups-Vie-to-Build-an-Uber-for-Health-Care2015-12-03https://www.sjordanassociates.com/blog/bid/374643/Vital-Signs-81-H-X-Hits-the-Road-Arizona-Crowdfunding2015-12-03https://www.sjordanassociates.com/blog/bid/406676/Disruption-In-Healthcare-Could-Be-Costly2015-12-03https://www.sjordanassociates.com/blog/bid/163235/17-Braving-the-IPO-Drought2015-12-03https://www.sjordanassociates.com/blog/bid/397850/Vital-Signs-109-Online-Venture-Funds-Why-Not2015-12-03https://www.sjordanassociates.com/transactions1-0https://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/La%20Zona%20Promo.m4v/medium.jpgLa Zona PromoLa Zona Promohttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/La%20Zona%20Promo.m4v32nonohttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/RaisingSpirits-LaZona_ExecSummary_Page_2-1.jpgRaisingSpiritsLaZonaExecSummaryPage21RaisingSpiritsLaZonaExecSummaryPage21https://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/AdobeStock_358780865%20(1).jpegAdobeStock3587808651AdobeStock3587808651https://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/RaisingSpirits-LaZona_ExecSummary_Page_5-2.jpgRaisingSpiritsLaZonaExecSummaryPage52RaisingSpiritsLaZonaExecSummaryPage52https://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/RaisingSpirits-LaZona_ExecSummary_Page_6-2.jpgRaisingSpiritsLaZonaExecSummaryPage62RaisingSpiritsLaZonaExecSummaryPage62https://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/RaisingSpirits-LaZona_ExecSummary_Page_4-2.jpgRaisingSpiritsLaZonaExecSummaryPage42RaisingSpiritsLaZonaExecSummaryPage42https://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/RaisingSpirits-LaZona_ExecSummary_Page_3-1.jpgRaisingSpiritsLaZonaExecSummaryPage31RaisingSpiritsLaZonaExecSummaryPage312025-07-09https://www.sjordanassociates.com/blog/bid/326356/Vital-Signs-71-HealthiosXchange-Healthcare-Crowdfunding-Portal2015-12-03https://www.sjordanassociates.com/blog/stemcentrx-sale-to-return-a-record-1.7-billion-for-vc-firm-founders-fundhttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/wsj-4.pngwsj4wsj4https://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/san_francisco.pngsanfranciscosanfranciscohttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/bloomberg-2.pngbloomberg2bloomberg22016-04-29https://www.sjordanassociates.com/blog/pfizer-partner-german-merck-see-fda-accept-pd-l1-candidate-for-speedy-reviewhttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/BBC-1.pngBBC1BBC1https://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/xpress.pngxpressxpresshttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/fierce.pngfiercefiercehttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/nyt.pngnytnyt2016-11-29https://www.sjordanassociates.com/blog/bid/404815/Vital-Signs-143-Lendit-Conference-Marketplace-Lending2015-12-03https://www.sjordanassociates.com/blog/gilman-scores-for-atlas-again-as-bristol-buys-padlock-for-up-to-600mhttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/xconomy.pngxconomyxconomyhttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/san_francisco.pngsanfranciscosanfrancisco2016-03-23https://www.sjordanassociates.com/blog/funding-for-early-stage-biopharma-dwindled-in-2015https://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/fierce.pngfiercefiercehttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/wsj1.pngwsj1wsj1https://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/xconomy.pngxconomyxconomy2016-07-15https://www.sjordanassociates.com/blog/bid/390628/Vital-Signs-95-FinTech-and-The-Rise-of-Alternative-Investing2015-12-03https://www.sjordanassociates.com/blog/ipo-market-comes-to-a-standstillhttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/images/wall_street.pngwallstreetwallstreethttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/BBC-1.pngBBC1BBC12016-01-31https://www.sjordanassociates.com/blog/bid/407062/Re-Boot-Venture-Capital-Investing-in-the-21st-Century2015-12-03https://www.sjordanassociates.com/blog/bid/319413/Vital-Signs-66-Crowdfunding-Webinar-Healthcare-Companies2015-12-03https://www.sjordanassociates.com/blog/bid/406758/Bill-Gates-and-others-just-invested-120-million-in-a-revolutionary-medical-startup2015-12-03https://www.sjordanassociates.com/blog/bid/163247/11-JPM-20122015-12-03https://www.sjordanassociates.com/blog/bid/365346/Vital-Signs-75-7th-Annual-OneMedForum-Crowdfunding2015-12-03https://www.sjordanassociates.com/blog/bid/393769/Vital-Signs-103-BIO-Investor-Forum-Crowdfunding2015-12-03https://www.sjordanassociates.com/blog/microsoft-will-solve-cancer-within-10-years-by-reprogramming-diseased-cellshttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/fierce.pngfiercefiercehttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/telegraph-1.pngtelegraph1telegraph12016-09-22https://www.sjordanassociates.com/blog/bid/366018/Vital-Signs-77-White-Paper-Crowdfunding-and-Life-Sciences2015-12-03https://www.sjordanassociates.com/blog/bid/407075/Why-DNA-editing-needs-to-stop2015-12-03https://www.sjordanassociates.com/blog/bid/391559/Vital-Signs-99-Self-Directed-IRA-s-Meet-Crowdfunding2015-12-03https://www.sjordanassociates.com/blog/bid/407398/A-comprehensive-guide-to-Theranos-s-troubles-and-what-it-means-for-you2015-12-03https://www.sjordanassociates.com/blog/bid/407547/CircleUp-Raises-30M-For-Its-Consumer-Brand-Crowdfunding-Platform2015-12-03https://www.sjordanassociates.com/blog/bid/407032/6-Billionaires-Who-Want-to-Live-Forever2015-12-03https://www.sjordanassociates.com/blog/bid/393142/Vital-Signs-100-The-Champion-s-Program-Crowdfunding2015-12-03https://www.sjordanassociates.com/blog/bid/300602/Vital-Signs-58-WSGR-Medical-Device-Conference-Crowdfunding2015-12-03https://www.sjordanassociates.com/blog/bid/404973/Ron-Suber-on-Marketplace-Lending2015-12-03https://www.sjordanassociates.com/blog/bid/246105/Vital-Signs-43-Crowdfunding-Platform-for-Broker-Dealers2015-12-03https://www.sjordanassociates.com/blog/bid/163227/25-Crowdfunding-Structures-in-the-Life-Sciences-Industry2015-12-03https://www.sjordanassociates.com/blog/bid/407318/Biotech-IPOs-Slow-to-Trickle-as-Stock-Rout-Rattles-Investors2015-12-03https://www.sjordanassociates.com/blog/bid/284114/Vital-Signs-54-Crowdfunding-Disruptive-to-Finance-Industry2015-12-03https://www.sjordanassociates.com/blog/bid/407011/Silicon-Valley-Unicorn-Bubble-Next-to-Burst2015-12-03https://www.sjordanassociates.com/blog/drugmakers-place-big-bets-on-cancer-medicineshttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/wsj-4.pngwsj4wsj4https://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/bloomberg-2.pngbloomberg2bloomberg2https://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/san_francisco.pngsanfranciscosanfrancisco2016-04-29https://www.sjordanassociates.com/blog/bid/330170/Vital-Signs-73-HealthiosXchange-Pullan-s-Pieces-Crowdfunding2015-12-03https://www.sjordanassociates.com/blog/bid/404629/Vital-Signs-142-Did-The-SEC-Just-Kill-Early-Stage-Venture-Capital2015-12-03https://www.sjordanassociates.com/blog/bid/407667/Is-Lab-Testing-the-Wild-West-of-Medicinehttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/xconomy.pngxconomyxconomyhttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/cnbc1.pngcnbc1cnbc12015-12-11https://www.sjordanassociates.com/public-company-exitshttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/SJA/S_Jordan_Associates_July2022/images/nas.pngnasnashttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/SJA/S_Jordan_Associates_July2022/images/shutterstock_192611012.jpgshutterstock192611012shutterstock1926110122025-07-09https://www.sjordanassociates.com/blog/bid/163248/10-Life-Sciences-Investor-Road-Shows-San-Diego-San-Francisco2015-12-03https://www.sjordanassociates.com/blog/bid/385871/Vital-Signs-92-How-Does-Equity-Crowdfunding-Resemble-Schwab2015-12-03https://www.sjordanassociates.com/blog/bid/407624/Ethicists-square-off-over-editing-genes-in-human-embryos2015-12-03https://www.sjordanassociates.com/blog/bid/163254/7-June-19-20112015-12-03https://www.sjordanassociates.com/blog/the-odd-juxtaposition-in-biotech-venture-capital-delivering-returns-amidst-sliding-market-sharehttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/lifesci.pnglifescilifescihttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/Forbes.jpgForbesForbes2016-08-24https://www.sjordanassociates.com/blog/bid/276673/Vital-Signs-51-Digital-Health-Article-Crowdfunding2015-12-03https://www.sjordanassociates.com/blog/bid/406300/Prenatal-Tester-Natera-Now-Shooting-for-175M-IPO2015-12-03https://www.sjordanassociates.com/private-company-financingshttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/SJA/S_Jordan_Associates_July2022/images/shutterstock_174967394.jpgshutterstock174967394shutterstock174967394https://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/SJA/S_Jordan_Associates_July2022/images/PP.pngPPPP2025-07-09https://www.sjordanassociates.com/blog/bid/163231/21-JOBS-Act-Jumpstart-Our-Business-Startups-Act2015-12-03https://www.sjordanassociates.com/blog/breakthrough-gene-technology-attracts-investors-amid-patent-disputehttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/xconomy.pngxconomyxconomy2016-09-22https://www.sjordanassociates.com/blog/bid/365347/Vital-Signs-76-Crowdfunding-Presentation-Harvard-HBSAB2015-12-03https://www.sjordanassociates.com/blog/bid/403894/Vital-Signs-128-The-Uber-of-Healthcare2015-12-03https://www.sjordanassociates.com/blog/bid/278520/Vital-Signs-53-Circleup-Raises-7-5-Million-Crowdfunding2015-12-03https://www.sjordanassociates.com/blog/bid/406117/A-29-year-old-former-Wall-Streeter-bought-an-Alzheimer-s-drug-that-failed-clinical-trials-and-now-his-company-is-worth-3-billionhttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/xconomy.pngxconomyxconomy2015-12-03https://www.sjordanassociates.com/blog/bid/364493/Crowdfunding-A-Year-in-Review2015-12-03https://www.sjordanassociates.com/blog/bid/403078/Vital-Signs-123-AngelList-Tapping-into-Investor-Cash2015-12-03https://www.sjordanassociates.com/blog/bid/404924/Prosper-And-OnDeck-Get-Closer2015-12-03https://www.sjordanassociates.com/blog/scientists-talk-privately-about-creating-a-synthetic-human-genomehttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/nyt.pngnytnythttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/fortune-3.pngfortune3fortune32016-05-14https://www.sjordanassociates.com/blog/bid/163259/2-Oncology-March-14-2011https://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/fierce.pngfiercefierce2015-12-03https://www.sjordanassociates.com/blog/220m-richer-human-longevityhttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/xconomy-1.pngxconomy1xconomy12016-04-05https://www.sjordanassociates.com/blog/bid/406299/Vertex-Pharma-s-lung-disorder-therapy-wins-FDA-nodhttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/lifesci.pnglifescilifescihttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/xconomy.pngxconomyxconomy2015-12-03https://www.sjordanassociates.com/blog/bid/323773/Vital-Signs-68-Crowdfunding-Portals-Profiled-by-TheCrowdCafe-comhttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/xconomy.pngxconomyxconomy2015-12-03https://www.sjordanassociates.com/blog/bid/406480/The-rise-of-the-thematic-VC-and-what-it-means-for-foundershttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/lifesci.pnglifescilifesci2015-12-03https://www.sjordanassociates.com/blog/bid/364496/8-Crowdfunding-predictions-for-20142015-12-03https://www.sjordanassociates.com/blog/bid/385725/Vital-Signs-91-Convergence-Summit-2014-Crowdfunding2015-12-03https://www.sjordanassociates.com/contact-ushttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/SJA/S_Jordan_Associates_July2022/images/Cover-Photo-Compressed-1.jpgCoverPhotoCompressed1CoverPhotoCompressed1https://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/SJA/S_Jordan_Associates_July2022/images/image-asset.pngimageassetimageasset2026-01-23https://www.sjordanassociates.com/blog/bid/315882/Vital-Signs-64-SEC-Lifts-Band-on-General-Solicitation2015-12-03https://www.sjordanassociates.com/blog/bid/407414/23andme-relaunches-its-expanded-DNA-spit-tests-after-FDA-mandated-pausehttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/business_insider.pngbusinessinsiderbusinessinsider2015-12-03https://www.sjordanassociates.com/blog/bid/400260/Vital-Signs-113-HealthiosXChange-Collaborates-with-MATTER2015-12-03https://www.sjordanassociates.com/blog/bid/405199/Minimizing-the-Pain-of-Raising-Capital2015-12-03https://www.sjordanassociates.com/blog/bid/407289/Here-s-what-doctors-can-learn-from-global-volunteering2015-12-03https://www.sjordanassociates.com/blog/tesaros-parp-ovarian-cancer-drug-hits-phiii-goal-prepares-to-filehttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/fierce.pngfiercefierce2016-06-30https://www.sjordanassociates.com/blog/bid/404612/Vital-Signs-140-Wall-Street-and-Big-Data2015-12-03https://www.sjordanassociates.comhttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/SJA/S_Jordan_Associates_July2022/images/Contact-Photo-Compressed.jpgContactPhotoCompressedContactPhotoCompressedhttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/SJA/S_Jordan_Associates_July2022/images/Screen%2BShot%2B2020-05-24%2Bat%2B9.08.16%2BAM.pngScreenShot20200524at90816AMScreenShot20200524at90816AMhttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/SJA/S_Jordan_Associates_July2022/images/SJA-E-News.jpgSJAENewsSJAENewshttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/SJA/S_Jordan_Associates_July2022/images/iStock-1144696578%2Bcopy.jpgiStock1144696578copyiStock1144696578copyhttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/SJA/S_Jordan_Associates_July2022/images/Scott-Jordan.jpgScottJordanScottJordanhttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/SJA/S_Jordan_Associates_July2022/images/10-ipad-mockup.jpg10ipadmockup10ipadmockuphttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/SJA/S_Jordan_Associates_July2022/images/shutterstock_52612465.jpgshutterstock52612465shutterstock52612465https://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/SJA/S_Jordan_Associates_July2022/images/shutterstock_88062910.jpgshutterstock88062910shutterstock88062910https://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/SJA/S_Jordan_Associates_July2022/images/stephen-dawson-qwtCeJ5cLYs-unsplash%20(1).jpgstephendawsonqwtCeJ5cLYsunsplash1stephendawsonqwtCeJ5cLYsunsplash1https://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/SJA/S_Jordan_Associates_July2022/images/markus-spiske-3Tf1J8q9bBA-unsplash.jpgmarkusspiske3Tf1J8q9bBAunsplashmarkusspiske3Tf1J8q9bBAunsplashhttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/SJA/S_Jordan_Associates_July2022/images/stephen-dawson-qwtCeJ5cLYs-unsplash-1.jpgstephendawsonqwtCeJ5cLYsunsplash1stephendawsonqwtCeJ5cLYsunsplash12026-01-06https://www.sjordanassociates.com/blog/bid/407237/Is-the-Fintech-Sector-Overheating2015-12-03https://www.sjordanassociates.com/blog/bid/276937/Vital-Signs-52-Venture-Capital-Investments-Decline-Crowdfunding-Answer2015-12-03https://www.sjordanassociates.com/blog/bid/161864/29-Crowdfunding-Inbound-Marketing-Platforms-SJAConnect2015-12-03https://www.sjordanassociates.com/blog/bid/385719/Vital-Signs-90-PENSCO-HealthiosXchange-Crowdfunding-Webinar2015-12-03https://www.sjordanassociates.com/blog/bid/405870/Genentech-Brain-Trust-Leaves-With-217-Million-For-New-Startup-To-Fight-Alzheimer-s-And-Parkinson-s2015-12-03https://www.sjordanassociates.com/blog/bid/397052/Vital-Signs-108-Crowdfunding-Will-Predict-the-Future2015-12-03https://www.sjordanassociates.com/blog/bid/402846/Vital-Signs-120-How-to-build-a-710-Million-Biotech-in-Silicon-Valley2015-12-03https://www.sjordanassociates.com/blog/bid/374667/Vital-Signs-82-Fueling-Equity-Crowdfunding-s-Rise-Crowdfund-Funds2015-12-03https://www.sjordanassociates.com/blog/bid/393739/Vital-Signs-102-Investor-Syndicates-The-Champion-s-Program2015-12-03https://www.sjordanassociates.com/blog/us-bid-to-grow-human-organs-for-transplant-inside-pigshttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/BBC-1.pngBBC1BBC1https://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/xpress.pngxpressxpresshttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/fierce.pngfiercefiercehttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/wsj-4.pngwsj4wsj42016-06-06https://www.sjordanassociates.com/blog/a-cancer-startup-just-raised-175-million-from-a-pharmaceutical-giant-and-it-could-be-where-the-industry-is-headedhttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/business_insider.pngbusinessinsiderbusinessinsider2016-05-03https://www.sjordanassociates.com/blog/bid/387360/Vital-Signs-93-SJA-Research-Profiled-in-TABB-Forum2015-12-03https://www.sjordanassociates.com/blog/bid/163242/13-Crowdfunding-Can-It-Fill-the-Innovation-Gap-in-Biotechnology2015-12-03https://www.sjordanassociates.com/blog/bid/404789/Venture-Capital-target-fintech-in-first-quarter2015-12-03https://www.sjordanassociates.com/blog/bid/404833/The-Rise-of-Alternative-Finance-Silicon-Valley-is-coming2015-12-03https://www.sjordanassociates.com/blog/bid/407473/Nasdaq-Unveils-Blockchain-Enabled-Platform-Linq-Announces-6-Inaugural-Clients2015-12-03https://www.sjordanassociates.com/blog/bid/404916/It-s-Official-Prosper-Is-A-Unicorn2015-12-03https://www.sjordanassociates.com/blog/bid/404714/Patch-of-Land-Raises-23-6-Million-in-Financing-Led-by-SF-Capital-Group-and-Ron-Suber2015-12-03https://www.sjordanassociates.com/blog/bid/404052/Vital-Signs-130-Raising-Capital-on-HealthiosXchange2015-12-03https://www.sjordanassociates.com/blog/bid/209043/Vital-Signs-37-Launch-of-Healthios-Xchange-Crowdfunding2015-12-03https://www.sjordanassociates.com/blog/bid/399097/Vital-Signs-110-Will-Equity-Crowdfunding-Catch-up-to-Peer-to-Peer-Lending2015-12-03https://www.sjordanassociates.com/blog/bid/406245/Here-s-what-it-takes-to-be-the-next-great-digital-health-startup2015-12-03https://www.sjordanassociates.com/blog/bid/402778/Vitals-Signs-119-Social-Media-Transforming-Alternative-Investing2015-12-03https://www.sjordanassociates.com/blog/bid/323511/Vital-Signs-67-Crowdunding-MedCityNews-Profiles-HealthiosXchangehttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/images/wall_street.pngwallstreetwallstreet2015-12-03https://www.sjordanassociates.com/blog/bid/391558/Vital-Signs-99-Self-Directed-IRA-s-Meet-Crowdfunding2015-12-03https://www.sjordanassociates.com/blog/bid/236617/Vital-Signs-40-Democratization-of-Capital-Crowdfunding2015-12-03https://www.sjordanassociates.com/blog/bid/407616/Why-the-U-S-Pays-More-Than-Other-Countries-for-Drugshttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/cnbc1.pngcnbc1cnbc12015-12-03https://www.sjordanassociates.com/blog/bid/406609/Y-Combinator-Backed-Ixchel-Predicts-How-Cancer-Drugs-Will-Behave-In-Humans-Before-You-Even-Swallow-A-Pill2015-12-03https://www.sjordanassociates.com/blog/bid/393954/Vital-Signs-104-TABB-Group-Profiles-Investor-Syndicates-Crowdfunding2015-12-03https://www.sjordanassociates.com/blog/bid/382942/Vital-Signs-88-Crowdfunding-and-the-Direct-Investing-Revolution2015-12-03https://www.sjordanassociates.com/blog/bid/307954/Vital-Signs-61-WSGR-Medical-Device-Conference-Crowdfunding2015-12-03https://www.sjordanassociates.com/blog/bid/404995/8-emerging-sectors-in-fintech2015-12-03https://www.sjordanassociates.com/blog/bid/407069/ShareVault-Partners-and-Alliances2015-12-03https://www.sjordanassociates.com/blog/bid/405221/The-Top-10-Venture-Investors-And-Firms-Of-2015https://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/Forbes.jpgForbesForbes2015-12-03https://www.sjordanassociates.com/blog/bid/405497/BioPharma-M-A-Capital-Efficiency-Drives-Returnshttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/lifesci.pnglifescilifesci2015-12-03https://www.sjordanassociates.com/blog/bid/381297/Vital-Signs-86-TABB-MarketTech-2014-Game-of-Smarts-Crowdsourcing2015-12-03https://www.sjordanassociates.com/blog/bid/287023/Vital-Signs-56-Crowdfunding-is-Eating-the-World2015-12-03https://www.sjordanassociates.com/blog/biotech-labs-birth-new-drugs-and-new-fortuneshttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/fortune.pngfortunefortunehttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/wsj1.pngwsj1wsj1https://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/xconomy.pngxconomyxconomy2016-06-25https://www.sjordanassociates.com/blog/bid/163255/6-Oncology-May-1-20112015-12-03https://www.sjordanassociates.com/blog/bid/405100/Lendit-2015-Recap2015-12-03https://www.sjordanassociates.com/blog/ibm-to-buy-truven-health-analytics-for-2.6-billionhttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/xconomy.pngxconomyxconomyhttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/wall_street-1.pngwallstreet1wallstreet12016-02-18https://www.sjordanassociates.com/blog/bid/403382/Vital-Signs-125-New-HealthiosXchange-Member-Page2015-12-03https://www.sjordanassociates.com/blog/bid/407021/Be-Unrealistic-The-Only-Path-To-Breakthrough-Successhttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/wsj-4.pngwsj4wsj42015-12-03https://www.sjordanassociates.com/blog/bid/388579/Vital-Signs-94-Text-Analytics-Meets-Crowdfunding2015-12-03https://www.sjordanassociates.com/blog/bid/406417/18-VCs-That-Made-The-Jump-To-Entrepreneurs2015-12-03https://www.sjordanassociates.com/blog/bid/197223/Vital-Signs-33-The-Most-Important-New-Drug-Of-20122015-12-03https://www.sjordanassociates.com/blog/new-online-tools-offer-path-to-lower-drug-priceshttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/wsj1.pngwsj1wsj1https://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/lifesci.pnglifescilifescihttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/nyt.pngnytnyt2016-02-12https://www.sjordanassociates.com/transactions1https://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/SJA/S_Jordan_Associates_July2022/images/Success%20(1).pngSuccess1Success1https://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/SJA/S_Jordan_Associates_July2022/images/iStock-1186943976%2Bcopy.jpgiStock1186943976copyiStock1186943976copyhttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/Screenshot%202025-09-17%20at%204.19.52%20PM.pngScreenshot20250917at41952PMScreenshot20250917at41952PM2025-09-17https://www.sjordanassociates.com/blog/bid/394618/Vital-Signs-106-Crowdfunding-Crowdsourcing-Going-Viral2015-12-03https://www.sjordanassociates.com/blog/pharmas-productivity-problem-finding-more-blockbuster-drugshttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/lifesci.pnglifescilifescihttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/xconomy.pngxconomyxconomy2016-09-22https://www.sjordanassociates.com/non-dilutive-fundinghttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/SJA/S_Jordan_Associates_July2022/images/stephen-dawson-qwtCeJ5cLYs-unsplash.jpgstephendawsonqwtCeJ5cLYsunsplashstephendawsonqwtCeJ5cLYsunsplashhttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/SJA/S_Jordan_Associates_July2022/images/non-dilute.pngnondilutenondilute2025-07-09https://www.sjordanassociates.com/blog/bid/404261/Vital-Signs-132-HeathTech-Rising-MATTER-Chicago2015-12-03https://www.sjordanassociates.com/blog/bid/403952/Vital-Signs-130-Group-Intelligence-vs-The-Experts2015-12-03https://www.sjordanassociates.com/blog/bid/383332/Vital-Signs-89-Mid-America-Healthcare-Venture-Forum-Crowdfunding2015-12-03https://www.sjordanassociates.com/blog/bid/396621/Vital-Signs-107-Equity-Crowdfunding-and-Life-Science-Companies2015-12-03https://www.sjordanassociates.com/blog/blue-cross-invests-in-hygieia-partners-on-diabetes-management-pilothttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/xconomy.pngxconomyxconomy2016-04-15https://www.sjordanassociates.com/blog/bid/407435/You-can-now-print-human-tissue-with-the-10-000-Biobot1-machinehttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/fortune-3.pngfortune3fortune32015-12-03https://www.sjordanassociates.com/blog/bid/403692/Vital-Signs-126-MATTER-Events-Week-of-March-2-20152015-12-03https://www.sjordanassociates.com/blog/bid/163243/12-Article-Confirms-Challenges-Facing-Early-Stage-Biotech-Companies2015-12-03https://www.sjordanassociates.com/blog/bid/406940/Will-Wall-Street-Volatility-Dampen-The-Sizzling-Biotech-IPO-Market2015-12-03https://www.sjordanassociates.com/blog/bid/377887/Vital-Signs-83-HealthiosXchange-Road-Shows-Crowdfunding2015-12-03https://www.sjordanassociates.com/blog/bid/407378/Steven-Fang-sees-opportunities-in-Singapore-s-location2015-12-03https://www.sjordanassociates.com/blog/bid/405799/Cancer-breakthroughs-trigger-big-pharma-interest-in-drugs-and-deals2015-12-03https://www.sjordanassociates.com/blog/zuckerberg-and-chan-latest-wealthy-philanthropists-to-attempt-to-cure-all-diseasehttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/telegraph-1.pngtelegraph1telegraph1https://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/images/wall_street.pngwallstreetwallstreethttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/nyt.pngnytnythttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/fierce.pngfiercefierce2016-09-22https://www.sjordanassociates.com/blog/bid/163222/26-Charity-and-Non-Profit-Platform-Rally-org-Obtained-7-9-Million-from-Investors2015-12-03https://www.sjordanassociates.com/blog/bid/406755/6-Predictions-for-Alphabet-and-the-New-Googlehttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/wsj-4.pngwsj4wsj42015-12-03https://www.sjordanassociates.com/blog/bid/406859/The-Next-Moody-s-Orchard-Platform-Is-A-Guide-To-The-Exploding-Peer-To-Peer-Lending-Industry2015-12-03https://www.sjordanassociates.com/blog/bid/407083/SGX-gives-S-1-5m-grant-to-develop-equity-crowdfunding-platform-CapBridge2015-12-03https://www.sjordanassociates.com/blog/can-sean-parker-hack-cancerhttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/san_francisco.pngsanfranciscosanfranciscohttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/fortune.pngfortunefortune2016-04-30https://www.sjordanassociates.com/blog/bid/403285/Vital-Signs-124-MATTER-Launches-in-Chicago2015-12-03https://www.sjordanassociates.com/blog/software-is-disrupting-venture-capital-sectorhttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/xconomy-1.pngxconomy1xconomy1https://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/wall_street-1.pngwallstreet1wallstreet12016-03-07https://www.sjordanassociates.com/blog/bid/405394/The-fintech-revolution2015-12-03https://www.sjordanassociates.com/blog/bid/197270/Vital-Signs-34-Study-More-Than-1-000-Seed-Funded-Startups-Are-Destined-To-Be-Orphaned-At-The-Series-A-Stage2015-12-03https://www.sjordanassociates.com/sample-abouthttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/AUM/AUM/AUM%20Biosciences%20Logo.pngAUMBiosciencesLogoAUMBiosciencesLogo2020-01-28https://www.sjordanassociates.com/blog/bid/407450/NASDAQ-acquires-SecondMarket-to-expand-its-reach-into-private-company-trading2015-12-03https://www.sjordanassociates.com/blog/bid/402336/Vital-Signs-118-MATTER-Partners-with-Healthios2015-12-03https://www.sjordanassociates.com/blog/bid/406238/Global-health-tracking-technology-market-to-reach-18-8B-in-20192015-12-03https://www.sjordanassociates.com/blog/bid/407415/Collective-Health-takes-81M-from-Google-Ventures-others-to-go-nationwide2015-12-03https://www.sjordanassociates.com/blog/bid/246071/Vital-Signs-42-CrowdfundConnect-Crowdfunding2015-12-03https://www.sjordanassociates.com/blog/bid/163229/23-Is-Equity-Crowdfunding-a-Viable-Financing-Vehicle2015-12-03https://www.sjordanassociates.com/blog/bid/300804/Vital-Signs-59-Presentation-at-AM-AA-Conference-Crowdfunding2015-12-03https://www.sjordanassociates.com/blog/bid/407468/Silicon-Valley-Goes-After-Wall-Street-Financial-Services-Technology2015-12-03https://www.sjordanassociates.com/blog/bid/406116/Pharma-Execs-Don-t-Know-Why-Anyone-Is-Upset-by-a-94-500-Miracle-Curehttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/wsj1.pngwsj1wsj1https://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/fortune.pngfortunefortune2015-12-03https://www.sjordanassociates.com/blog/bid/406664/Forget-About-The-Apple-Watch-Implantables-Are-Coming2015-12-03https://www.sjordanassociates.com/blog/bid/393678/Vital-Signs-101-PENSCO-HealthiosXchange-Crowdfunding2015-12-03https://www.sjordanassociates.com/blog/bid/401649/Vital-Signs-117-Join-HealthiosXchange-Reception-at-JPM2015-12-03https://www.sjordanassociates.com/blog/big-pharma-short-on-blockbusters-outsources-the-science2016-12-12https://www.sjordanassociates.com/blog/bid/399851/Vital-Signs-111-Marketplace-Lending-Crowdfunding-New-Asset-Classes2015-12-03https://www.sjordanassociates.com/blog/bid/407033/Novartis-to-Begin-Selling-Copy-of-Amgen-s-Neupogen-in-U-S2015-12-03https://www.sjordanassociates.com/blog/bid/329761/Vital-Signs-72-SXSW-Presentation-Crowdfunding-Panel2015-12-03https://www.sjordanassociates.com/blog/bid/163228/24-H-X-ASCO-20122015-12-03https://www.sjordanassociates.com/blog/bid/197277/Vital-Signs-35-Private-equity-for-the-average-Joe-It-s-coming2015-12-03https://www.sjordanassociates.com/blog/bid/163221/27-EarlyShares-Raises-1-15-Million-Equity-Crowdfunding2015-12-03https://www.sjordanassociates.com/blog/bid/391380/Vital-Signs-98-CrowdFundConnect-Launches-New-Website-Crowdfunding2015-12-03https://www.sjordanassociates.com/blog/bid/404089/Vital-Signs-131-A-shadow-banking-sector-has-gotten-65-times-larger2015-12-03https://www.sjordanassociates.com/blog/pfizer-beats-out-sanofi-to-take-medivation-for-14-billionhttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/wsj1.pngwsj1wsj1https://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/bloomberg-2.pngbloomberg2bloomberg2https://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/san_francisco.pngsanfranciscosanfrancisco2016-08-23https://www.sjordanassociates.com/blog/bid/275998/Vital-Signs-50-Crowdfunding-Strategics2015-12-03https://www.sjordanassociates.com/blog/bid/390976/Vital-Signs-97-HealthiosXchange-Speaking-Engagement-Crowdfunding2015-12-03https://www.sjordanassociates.com/blog/bid/406450/CircleUp-Captures-22M-to-Invest-in-Consumer-Brands-That-Campaigned-on-Its-Very-Own-Platform2015-12-03https://www.sjordanassociates.com/blog/bid/393993/Vital-Signs-105-TABB-Forum-HealthiosXchange-Presentation2015-12-03https://www.sjordanassociates.com/blog/bid/314359/Vital-Signs-63-The-Rise-of-Meaningful-Investing-Crowdfunding2015-12-03https://www.sjordanassociates.com/blog/bid/403951/Vital-Signs-129-Google-Ventures-and-the-Search-for-Immortalityhttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/wsj1.pngwsj1wsj12015-12-03https://www.sjordanassociates.com/blog/bid/324941/Vital-Signs-70-The-Crowdcafe-Weekly-HealthiosXchange-Crowdfunding2015-12-03https://www.sjordanassociates.com/blog/bid/163258/3-Oncology-April-3-20112015-12-03https://www.sjordanassociates.com/blog/bid/406597/The-Long-Game-Google-Backed-Calico-Partners-With-Ancestry-to-Beat-the-Specter-of-Aginghttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/business_insider.pngbusinessinsiderbusinessinsider2015-12-03https://www.sjordanassociates.com/blog/bid/404538/Vital-Signs-138-Prosper-Hits-Escape-Velocity2015-12-03https://www.sjordanassociates.com/blog/bid/404513/Vital-Signs-135-Silicon-Valley-Employees-Cash-in-Earlyhttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/wsj1.pngwsj1wsj12015-12-03https://www.sjordanassociates.com/opportunities-1https://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/meditope.jpgmeditopemeditopehttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/Imagin-IMage-FINAL-WHITE.jpgImaginIMageFINALWHITEImaginIMageFINALWHITEhttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/immuno%20logo.pngimmunologoimmunologohttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/SJA/S_Jordan_Associates_July2022/images/shutterstock_88062886-2.jpgshutterstock880628862shutterstock880628862https://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/MED-FINAL-IMAGE--1.jpgMEDFINALIMAGE1MEDFINALIMAGE12025-07-09https://www.sjordanassociates.com/blog/bid/407216/Report-Few-unicorns-top-list-of-largest-VC-backed-digital-health-exits-but-how-will-2015-measure-up2015-12-03https://www.sjordanassociates.com/blog/bid/407524/The-Uberization-of-Money2015-12-03https://www.sjordanassociates.com/blog/bid/247430/Vital-Signs-44-Crowdfunding-Revolution2015-12-03https://www.sjordanassociates.com/about-ushttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/Scott.jpgScottScotthttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/Corey-for-SJA-site.jpgCoreyforSJAsiteCoreyforSJAsitehttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/chris.jpgchrischrishttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/SJA/S_Jordan_Associates_July2022/images/Cover-Photo-Compressed-1.jpgCoverPhotoCompressed1CoverPhotoCompressed12025-08-27https://www.sjordanassociates.com/blog/bid/407660/Engineering-Red-Blood-Cells-Into-Drugs-Rubius-Snags-25M-From-Flagship2015-12-11https://www.sjordanassociates.com/blog/bid/221525/Vital-Signs-38-Equity-Crowdfunding-Webinar2015-12-03https://www.sjordanassociates.com/blog/bid/163236/16-Small-Business-Groups-Urge-U-S-Senate-to-Move-Forward-with-Crowdfunding-Legislation2015-12-03https://www.sjordanassociates.com/blog/bid/194213/Vital-Signs-32-CrowdfundConnect-H-X-Exchange2015-12-03https://www.sjordanassociates.com/blog/bid/163237/15-Life-Sciences-Investor-Road-Show-Boston-Pullan-Consulting-SJA2015-12-03https://www.sjordanassociates.com/blog/bid/406679/Setting-The-Right-Valuation-For-A-Competitive-Series-A-Round2015-12-03https://www.sjordanassociates.com/blog/bid/372096/Vital-Signs-79-HealthiosXchange-Speaking-Engagement-San-Diego-Venture-Group2015-12-03https://www.sjordanassociates.com/blog/bid/264089/Vital-Signs-46-BIO-Conference-Crowdfunding2015-12-03https://www.sjordanassociates.com/blog/bid/405396/A-Bitcoin-Technology-Gets-Nasdaq-Testhttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/wsj-4.pngwsj4wsj42015-12-03https://www.sjordanassociates.com/blog/setting-the-bodys-serialkillers-loose-on-cancerhttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/fortune.pngfortunefortunehttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/nyt-1.pngnyt1nyt12016-08-03https://www.sjordanassociates.com/blog/bid/403865/Vital-Signs-127-MIDWEST-UNIVERSITY-HEALTHTECH-SHOWCASE2015-12-03https://www.sjordanassociates.com/blog/bid/390722/Vital-Signs-96-David-Loucks-Introducing-HealthiosXchange2015-12-03https://www.sjordanassociates.com/blog/bid/407269/These-Russian-Scientists-Are-On-A-Quest-To-Extend-Human-Life2015-12-03https://www.sjordanassociates.com/blog/the-top-10-venture-capital-investors-in-the-world-midas-list-2016https://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/Forbes.jpgForbesForbes2016-03-26https://www.sjordanassociates.com/blog/bid/406927/Gilead-Waiting-Is-the-Best-Part2015-12-03https://www.sjordanassociates.com/blog/bid/163234/18-Update-from-Angel-Capital-Association-Meeting-Austin-TX-Crowdfunding2015-12-03https://www.sjordanassociates.com/blog/bid/406560/Meet-the-Top-5-FinTech-Disruptorshttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/wall_street-1.pngwallstreet1wallstreet12015-12-03https://www.sjordanassociates.com/blog/bid/404627/Vital-Signs-141-Project-Defy-Death2015-12-03https://www.sjordanassociates.com/bloghttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/xconomy.pngxconomyxconomyhttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/fierce.pngfiercefiercehttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/medcity.pngmedcitymedcityhttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/xpress.pngxpressxpresshttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/lifesci.pnglifescilifescihttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/telegraph-1.pngtelegraph1telegraph12022-07-20https://www.sjordanassociates.com/blog/bid/319194/Vital-Signs-65-HealthiosXchange-Hires-Leverage-PR-Crowdfunding2015-12-03https://www.sjordanassociates.com/blog/bid/407393/Within-Venture-A-Booming-Biotech-Sector-Is-Shrinkinghttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/lifesci.pnglifescilifesci2015-12-03https://www.sjordanassociates.com/blog/bid/373209/Vital-Signs-80-Join-H-X-Webinar-Series-JOBS-Act2015-12-03https://www.sjordanassociates.com/blog/bid/404526/Vital-Signs-137-A-Super-Angel-s-View-On-Venture-Capital-In-20152015-12-03https://www.sjordanassociates.com/blog/why-biotechs-biggest-breakthrough-is-now-in-disputehttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/fortune-3.pngfortune3fortune3https://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/xconomy.pngxconomyxconomy2016-01-31https://www.sjordanassociates.com/blog/attract-visitors-with-compelling-blog-content-sample2019-10-01https://www.sjordanassociates.com/blog/bid/404611/Vital-Signs-139-VCs-Create-New-Inside-Track2015-12-03https://www.sjordanassociates.com/blog/7-ways-regulation-a-is-better-than-traditional-venture-capitalhttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/Forbes.jpgForbesForbes2016-05-08https://www.sjordanassociates.com/blog/study-finds-link-between-molecular-mechanisms-in-prostate-cancer-and-ewings-sarcomahttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/wsj-4.pngwsj4wsj4https://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/xpress.pngxpressxpress2016-10-25https://www.sjordanassociates.com/blog/bid/406911/At-Silicon-Valley-Bank-risky-tech-start-ups-are-lucrative-business2015-12-03https://www.sjordanassociates.com/blog/bid/406884/Online-Lender-Social-Finance-s-Latest-Fundraising-Implies-4-Billion-Valuation2015-12-03https://www.sjordanassociates.com/blog/bid/407132/The-Finanser-Interviews-Ron-Suber-President-Prosper2015-12-03https://www.sjordanassociates.com/blog/bid/332946/Vital-Signs-74-HealthiosXchange-Reaches-450-Members-Crowdfunding2015-12-03https://www.sjordanassociates.com/blog/third-rock-gets-616m-to-grow-new-crop-of-biotech-startupshttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/xconomy.pngxconomyxconomyhttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/Forbes.jpgForbesForbes2016-11-01https://www.sjordanassociates.com/blog/bid/401221/Vital-Signs-114-How-HealthiosXchange-Works-for-Companies2015-12-03https://www.sjordanassociates.com/blog/bid/406973/More-investors-turn-to-P2P-lenders-for-high-yield2015-12-03https://www.sjordanassociates.com/sample-contacthttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/AUM/AUM/AUM%20Biosciences%20Logo.pngAUMBiosciencesLogoAUMBiosciencesLogo2020-01-28https://www.sjordanassociates.com/blog/bid/407214/Pharma-Bro-Is-the-Face-of-U-S-Health-Care2015-12-03https://www.sjordanassociates.com/blog/bid/371694/Vital-Signs-78-Milken-Institute-Roundtable-Discussion-Crowdfunding2015-12-03https://www.sjordanassociates.com/blog/bid/406539/From-Social-Networks-To-Market-Networks2015-12-03https://www.sjordanassociates.com/blog/this-big-biotech-boosts-its-deep-bay-area-cancer-fighting-portfoliohttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/wsj1.pngwsj1wsj1https://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/wsj-4.pngwsj4wsj4https://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/san_francisco.pngsanfranciscosanfranciscohttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/xconomy-1.pngxconomy1xconomy12016-08-09https://www.sjordanassociates.com/blog/bid/163218/28-Iamscientist-Kickstarter-for-Academic-Research2015-12-03https://www.sjordanassociates.com/blog/7-new-blockbuster-drugs-to-watch-in-2016https://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/fortune.pngfortunefortunehttps://200192.fs1.hubspotusercontent-na1.net/hubfs/200192/nyt.pngnytnyt2016-03-26https://www.sjordanassociates.com/blog/bid/163241/14-Crowdfunding-Part-II-Can-It-Fill-the-Innovation-Gap-in-Biotechnology2015-12-03